The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?

F1000Research - Tập 5 - Trang 313
Norman Saunders1, Mark D. Habgood1, Kjeld Møllgård2, Katarzyna M. Dzięgielewska1
1Department of Pharmacology & Therapeutics, University of Melbourne, Parkville, Victoria
2Institute of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen

Tóm tắt

Barrier mechanisms in the brain are important for its normal functioning and development. Stability of the brain’s internal environment, particularly with respect to its ionic composition, is a prerequisite for the fundamental basis of its function, namely transmission of nerve impulses. In addition, the appropriate and controlled supply of a wide range of nutrients such as glucose, amino acids, monocarboxylates, and vitamins is also essential for normal development and function. These are all cellular functions across the interfaces that separate the brain from the rest of the internal environment of the body. An essential morphological component of all but one of the barriers is the presence of specialized intercellular tight junctions between the cells comprising the interface: endothelial cells in the blood-brain barrier itself, cells of the arachnoid membrane, choroid plexus epithelial cells, and tanycytes (specialized glial cells) in the circumventricular organs. In the ependyma lining the cerebral ventricles in the adult brain, the cells are joined by gap junctions, which are not restrictive for intercellular movement of molecules. But in the developing brain, the forerunners of these cells form the neuroepithelium, which restricts exchange of all but the smallest molecules between cerebrospinal fluid and brain interstitial fluid because of the presence of strap junctions between the cells. The intercellular junctions in all these interfaces are the physical basis for their barrier properties. In the blood-brain barrier proper, this is combined with a paucity of vesicular transport that is a characteristic of other vascular beds. Without such a diffusional restrain, the cellular transport mechanisms in the barrier interfaces would be ineffective. Superimposed on these physical structures are physiological mechanisms as the cells of the interfaces contain various metabolic transporters and efflux pumps, often ATP-binding cassette (ABC) transporters, that provide an important component of the barrier functions by either preventing entry of or expelling numerous molecules including toxins, drugs, and other xenobiotics.In this review, we summarize these influx and efflux mechanisms in normal developing and adult brain, as well as indicating their likely involvement in a wide range of neuropathologies.There have been extensive attempts to overcome the barrier mechanisms that prevent the entry of many drugs of therapeutic potential into the brain. We outline those that have been tried and discuss why they may so far have been largely unsuccessful. Currently, a promising approach appears to be focal, reversible disruption of the blood-brain barrier using focused ultrasound, but more work is required to evaluate the method before it can be tried in patients. Overall, our view is that much more fundamental knowledge of barrier mechanisms and development of new experimental methods will be required before drug targeting to the brain is likely to be a successful endeavor. In addition, such studies, if applied to brain pathologies such as stroke, trauma, or multiple sclerosis, will aid in defining the contribution of brain barrier pathology to these conditions, either causative or secondary.

Từ khóa


Tài liệu tham khảo

A Krogh, 1946, The active and passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally., Proc R Soc Lond B., 133, 140-200, 10.1098/rspb.1946.0008

N Saunders, 2014, The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history., Front Neurosci., 8, 404, 10.3389/fnins.2014.00404

L Stern, 1921, Recherches sur le liquide céphalo-rachidien. 1. Les rapports entre le liquide céphalo-rachidien et la circulation sanguine., Arch Int Physiol., 17, 138-192, 10.3109/13813452109146211

P Ehrlich, 1885, Das Sauerstoffbedürfnis des Organismus. Eine Farbenanalytische Studie.

M Lewandowsky, 1900, Zur Lehre von der Cerebrospinalflüssgkeit., Z Clin Med., 40, 480-494

E Goldmann, 1909, Die äussere und innere Sekretion des gesunden und kranken Organismus im Lichte der ‘vitalen Färbung

M Mäe, 2011, Getting to know the cast - cellular interactions and signaling at the neurovascular unit., Curr Pharm Des., 17, 2750-2754, 10.2174/138161211797440113

I Sá-Pereira, 2012, Neurovascular unit: a focus on pericytes., Mol Neurobiol., 45, 327-347, 10.1007/s12035-012-8244-2

J Alvarez, 2015, Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions., Neurobiol Dis., 74, 14-24, 10.1016/j.nbd.2014.09.016

S Liddelow, 2015, SnapShot: Astrocytes in Health and Disease., Cell., 162, 1170-1170.e1, 10.1016/j.cell.2015.08.029

M Brightman, 1969, Junctions between intimately apposed cell membranes in the vertebrate brain., J Cell Biol., 40, 648-677, 10.1083/jcb.40.3.648

S Nabeshima, 1975, Junctions in the meninges and marginal glia., J Comp Neurol., 164, 127-169, 10.1002/cne.901640202

C Brøchner, 2015, Outer brain barriers in rat and human development., Front Neurosci., 9, 75, 10.3389/fnins.2015.00075

B Engelhardt, 2009, The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction., Semin Immunopathol., 31, 497-511, 10.1007/s00281-009-0177-0

R Daneman, 2010, Pericytes are required for blood-brain barrier integrity during embryogenesis., Nature., 468, 562-566, 10.1038/nature09513

M Errede, 2014, The contribution of CXCL12-expressing radial glia cells to neuro-vascular patterning during human cerebral cortex development., Front Neurosci., 8, 324, 10.3389/fnins.2014.00324

D Caley, 1970, Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex., J Comp Neurol., 138, 31-47, 10.1002/cne.901380104

E Neuwelt, 2004, Mechanisms of disease: the blood-brain barrier., Neurosurgery., 54, 131-40, 10.1227/01.NEU.0000097715.11966.8E

B Krish, 1978, The functional and structural border of the neurohemal region of the median eminence., Cell Tissue Res., 192, 327-339, 10.1007/BF00220750

C Price, 2008, The area postrema: a brain monitor and integrator of systemic autonomic state., Neuroscientist., 14, 182-194, 10.1177/1073858407311100

K Møllgård, 1987, Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: a CSF-brain barrier., J Neurocytol., 16, 433-444, 10.1007/BF01668498

G Fossan, 1985, CSF-brain permeability in the immature sheep fetus: a CSF-brain barrier., Brain Res., 350, 113-124, 10.1016/0165-3806(85)90255-X

S Whish, 2015, The inner CSF-brain barrier: developmentally controlled access to the brain via intercellular junctions., Front Neurosci., 9, 16, 10.3389/fnins.2015.00016

H Davson, 1996, Physiology of the CSF and Blood-Brain Barriers.

H Damkier, 2013, Cerebrospinal fluid secretion by the choroid plexus., Physiol Rev., 93, 1847-1892, 10.1152/physrev.00004.2013

S Liddelow, 2013, Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach., PLoS One., 8, e65629, 10.1371/journal.pone.0065629

W Oldendorf, 1971, Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection., Am J Physiol., 221, 1629-1639, 10.1152/ajplegacy.1971.221.6.1629

R Daneman, 2010, The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells., PLoS One., 5, e13741, 10.1371/journal.pone.0013741

R Shawahna, 2011, Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels., Mol Pharm., 8, 1332-1341, 10.1021/mp200129p

E Geier, 2013, Profiling solute carrier transporters in the human blood-brain barrier., Clin Pharmacol Ther., 94, 636-639, 10.1038/clpt.2013.175

F Marques, 2011, Transcriptome signature of the adult mouse choroid plexus., Fluids Barriers CNS., 8, 10, 10.1186/2045-8118-8-10

H Ho, 2012, Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier., Front Pharmacol., 3, 154, 10.3389/fphar.2012.00154

S Liddelow, 2012, Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach., PLoS One., 7, e33554, 10.1371/journal.pone.0033554

N Saunders, 2013, Transporters of the blood-brain and blood-CSF interfaces in development and in the adult., Mol Aspects Med., 34, 742-752, 10.1016/j.mam.2012.11.006

I Kratzer, 2013, Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection., Fluids Barriers CNS., 10, 25, 10.1186/2045-8118-10-25

N Saunders, 2015, Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study., Front Neurosci., 9, 123, 10.3389/fnins.2015.00123

M Dean, 2001, The human ATP-binding cassette (ABC) transporter superfamily., Genome Res., 11, 1156-1166, 10.1101/gr.GR-1649R

A Hartz, 2011, ABC transporters in the CNS - an inventory., Curr Pharm Biotechnol., 12, 656-673, 10.2174/138920111795164020

N Strazielle, 2015, Efflux transporters in blood-brain interfaces of the developing brain., Front Neurosci., 9, 21, 10.3389/fnins.2015.00021

C Ek, 2010, Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat., Toxicol Lett., 197, 51-59, 10.1016/j.toxlet.2010.04.025

E Beaulieu, 1997, P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain., Biochem J., 326, 539-544, 10.1042/bj3260539

R Bendayan, 2002, Functional expression and localization of P-glycoprotein at the blood brain barrier., Microsc Res Tech., 57, 365-380, 10.1002/jemt.10090

L Roberts, 2008, Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation., Neuroscience., 155, 423-438, 10.1016/j.neuroscience.2008.06.015

H Cooray, 2002, Localisation of breast cancer resistance protein in microvessel endothelium of human brain., Neuroreport., 13, 2059-2063, 10.1097/00001756-200211150-00014

M Daood, 2008, ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS., Neuropediatrics., 39, 211-218, 10.1055/s-0028-1103272

B Bauer, 2008, Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier., J Cereb Blood Flow Metab., 28, 1222-1234, 10.1038/jcbfm.2008.16

A Nies, 2004, Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain., Neuroscience., 129, 349-360, 10.1016/j.neuroscience.2004.07.051

S Gazzin, 2008, Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces., J Comp Neurol., 510, 497-507, 10.1002/cne.21808

M Maliepaard, 2001, Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues., Cancer Res., 61, 3458-3464

Y Matsuoka, 1999, Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain., J Neurobiol., 39, 383-392, 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4

S Bougoin, 2008, Evidence that the choroids plexus in female sheep express P-glycoprotein., Neuro Endocrinol Lett., 29, 438-442

C Mercier, 2004, Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes., Brain Res., 1021, 32-40, 10.1016/j.brainres.2004.06.034

V Rao, 1999, Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier., Proc Natl Acad Sci USA., 96, 3900-3905, 10.1073/pnas.96.7.3900

W Löscher, 2005, Drug resistance in brain diseases and the role of drug efflux transporters., Nat Rev Neurosci., 6, 591-602, 10.1038/nrn1728

C Higgins, 1992, Is the multidrug transporter a flippase?, Trends Biochem Sci., 17, 18-21, 10.1016/0968-0004(92)90419-A

U Schumacher, 1997, The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain., Histochem Cell Biol., 108, 179-182, 10.1007/s004180050159

D Virgintino, 2008, Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development., J Neuropathol Exp Neurol., 67, 50-61, 10.1097/nen.0b013e31815f65d9

Y He, 2014, Cell-culture models of the blood-brain barrier., Stroke., 45, 2514-2526, 10.1161/STROKEAHA.114.005427

M Patel, 2009, Getting into the brain: approaches to enhance brain drug delivery., CNS Drugs., 23, 35-58, 10.2165/0023210-200923010-00003

J Lajoie, 2015, Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier., Annu Rev Pharmacol Toxicol., 55, 613-631, 10.1146/annurev-pharmtox-010814-124852

C Palmiotti, 2014, In vitro cerebrovascular modeling in the 21st century: current and prospective technologies., Pharm Res., 31, 3229-3250, 10.1007/s11095-014-1464-6

I Wilhelm, 2014, In vitro models of the blood-brain barrier for the study of drug delivery to the brain., Mol Pharm., 11, 1949-1963, 10.1021/mp500046f

D Stanimirovic, 2015, Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics., Expert Opin Drug Discov., 10, 141-155, 10.1517/17460441.2015.974545

A Wolff, 2015, In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches., J Pharm Sci., 104, 2727-2746, 10.1002/jps.24329

P Revest, 1994, Transendothelial electrical potential across pial vessels in anaesthetised rats: a study of ion permeability and transport at the blood-brain barrier., Brain Res., 652, 76-82, 10.1016/0006-8993(94)90319-0

J Macdonald, 2010, Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature., J Neurosci Res., 88, 1457-1474, 10.1002/jnr.22316

S Ohtsuki, 2013, Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model., Mol Pharm., 10, 289-296, 10.1021/mp3004308

G Cotzias, 1968, Experimental treatment of parkinsonism with L-Dopa., Neurology., 18, 276-277

H Qosa, 2015, Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders., Brain Res., 1628, 298-316, 10.1016/j.brainres.2015.07.005

P Grandjean, 2006, Developmental neurotoxicity of industrial chemicals., Lancet., 368, 2167-2178, 10.1016/S0140-6736(06)69665-7

S Rapoport, 1971, Reversible osmotic opening of the blood-brain barrier., Science., 173, 1026-1028, 10.1126/science.173.4001.1026

M Brightman, 1973, Osmotic opening of tight junctions in cerebral endothelium., J Comp Neurol., 152, 317-325, 10.1002/cne.901520402

E Neuwelt, 1979, Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery., J Clin Invest., 64, 684-688, 10.1172/JCI109509

N Doolittle, 2014, Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances., Adv Pharmacol., 71, 203-243, 10.1016/bs.apha.2014.06.002

M Bellavance, 2008, Recent advances in blood-brain barrier disruption as a CNS delivery strategy., AAPS J., 10, 166-177, 10.1208/s12248-008-9018-7

A Rodriguez, 2015, Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment., Pharmaceutics., 7, 175-187, 10.3390/pharmaceutics7030175

L Bakay, 1956, Development of the blood-brain barrier, 77-149

J Patrick, 1990, Ultrasound and the blood-brain barrier., Adv Exp Med Biol., 267, 369-381

K Hynynen, 2001, Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits., Radiology., 220, 640-646, 10.1148/radiol.2202001804

M Aryal, 2015, Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study., J Control Release., 204, 60-69, 10.1016/j.jconrel.2015.02.033

K Wei, 2013, Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine., AJNR Am J Neuroradiol., 34, 115-120, 10.3174/ajnr.A3150

A Burgess, 2013, Noninvasive and targeted drug delivery to the brain using focused ultrasound., ACS Chem Neurosci., 4, 519-526, 10.1021/cn300191b

K Timbie, 2015, Drug and gene delivery across the blood-brain barrier with focused ultrasound., J Control Release., 219, 61-75, 10.1016/j.jconrel.2015.08.059

S Meairs, 2015, Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles., Pharmaceutics., 7, 275-293, 10.3390/pharmaceutics7030275

D Paul, 2013, Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels., Microvasc Res., 86, 1-10, 10.1016/j.mvr.2012.12.001

W Pardridge, 2002, Drug and gene targeting to the brain with molecular Trojan horses., Nat Rev Drug Discov., 1, 131-139, 10.1038/nrd725

S Hindle, 2014, Barrier mechanisms in the Drosophila blood-brain barrier., Front Neurosci., 8, 414, 10.3389/fnins.2014.00414

S Limmer, 2014, The Drosophila blood-brain barrier: development and function of a glial endothelium., Front Neurosci., 8, 365, 10.3389/fnins.2014.00365

R Umans, 2012, Zebrafish as a model to study drug transporters at the blood-brain barrier., Clin Pharmacol Ther., 92, 567-570, 10.1038/clpt.2012.168

A Fleming, 2013, Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish., PLoS One., 8, e77548, 10.1371/journal.pone.0077548

O Fardel, 2015, Nature and uses of fluorescent dyes for drug transporter studies., Expert Opin Drug Metab Toxicol., 11, 1233-1251, 10.1517/17425255.2015.1053462

E Neuwelt, 2011, Engaging neuroscience to advance translational research in brain barrier biology., Nat Rev Neurosci., 12, 169-182, 10.1038/nrn2995

M Blanchette, 2015, Formation and maintenance of the BBB., Mech Dev., 138, 8-16, 10.1016/j.mod.2015.07.007

F Marques, 2015, The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system., Front Cell Neurosci., 9, 136, 10.3389/fncel.2015.00136

H Stolp, 2009, Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases., Neuropathol Appl Neurobiol., 35, 132-146, 10.1111/j.1365-2990.2008.01005.x

P Brown, 2004, Molecular mechanisms of cerebrospinal fluid production., Neuroscience., 129, 957-970, 10.1016/j.neuroscience.2004.07.003

V Murphy, 1989, Acidosis, acetazolamide, and amiloride: effects on 22Na transfer across the blood-brain and blood-CSF barriers., J Neurochem., 52, 1058-1063, 10.1111/j.1471-4159.1989.tb01847.x

H Damkier, 2007, Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues., Am J Physiol Regul Integr Comp Physiol., 293, R2136-46, 10.1152/ajpregu.00356.2007

M Pollay, 1985, Choroid plexus Na+/K+-activated adenosine triphosphatase and cerebrospinal fluid formation., Neurosurgery., 17, 768-772

C Johanson, 2008, Multiplicity of cerebrospinal fluid functions: New challenges in health and disease., Cerebrospinal Fluid Res., 5, 10, 10.1186/1743-8454-5-10

K Oshio, 2005, Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1., FASEB J., 19, 76-78, 10.1096/fj.04-1711fje

B Owler, 2010, Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus., Cerebrospinal Fluid Res., 7, 15, 10.1186/1743-8454-7-15

O Amtorp, 1974, The ontogenetic development of concentration differences for protein and ions between plasma and cerebrospinal fluid in rabbits and rats., J Physiol., 243, 387-400, 10.1113/jphysiol.1974.sp010759

C Johanson, 1990, Acetazolamide and insulin alter choroid plexus epithelial cell [Na+], pH, and volume., Am J Physiol., 258, F1538-46

N Bass, 1973, Postnatal development of bulk flow in the cerebrospinal fluid system of the albino rat: clearance of carboxyl-( 14C)inulin after intrathecal infusion., Brain Res., 52, 323-332, 10.1016/0006-8993(73)90668-9

C Johanson, 1974, Changes in CSF flow and extracellular space in the developing rat, 281-287, 10.1007/978-1-4684-3063-9_15

C Johanson, 1976, Developmental studies of the compartmentalization of water and electrolytes in the choroid plexus of the neonatal rat brain., Brain Res., 116, 35-48, 10.1016/0006-8993(76)90247-X

W Pardridge, 2012, Drug transport across the blood-brain barrier., J Cereb Blood Flow Metab., 32, 1959-1972, 10.1038/jcbfm.2012.126

Y Liang, 2015, The physiological role of drug transporters., Protein Cell., 6, 334-350, 10.1007/s13238-015-0148-2

B Bauer, 2005, Modulation of p-glycoprotein transport function at the blood-brain barrier., Exp Biol Med (Maywood)., 230, 118-127, 10.1177/153537020523000206

S Kantorovich, 2013, Influence of neuropathology on convection-enhanced delivery in the rat hippocampus., PLoS One., 8, e80606, 10.1371/journal.pone.0080606

N Abbott, 2013, Blood-brain barrier structure and function and the challenges for CNS drug delivery., J Inherit Metab Dis., 36, 437-449, 10.1007/s10545-013-9608-0

L Gherardini, 2014, Novel siRNA delivery strategy: a new “strand” in CNS translational medicine?, Cell Mol Life Sci., 71, 1-20, 10.1007/s00018-013-1310-8

D Yarnitsky, 2004, Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain., J Neurosurg., 101, 303-309, 10.3171/jns.2004.101.2.0303

D Yarnitsky, 2004, Increased BBB permeability by parasympathetic sphenopalatine ganglion stimulation in dogs., Brain Res., 1018, 236-240, 10.1016/j.brainres.2004.05.103

A Dereymaeker, 1977, An experimental permeabilization of the blood-brain barrier by electric field application., Eur Neurol., 15, 333-339, 10.1159/000114822

N Saunders, 2012, Barrier mechanisms in the developing brain., Front Pharmacol., 3, 46, 10.3389/fphar.2012.00046

E Frömter, 1972, Route of passive ion permeation in epithelia., Nat New Biol., 235, 9-13, 10.1038/newbio235009a0

C Ek, 2006, Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica)., J Comp Neurol., 496, 13-26, 10.1002/cne.20885

M Krueger, 2015, Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia., J Cereb Blood Flow Metab., 35, 292-303, 10.1038/jcbfm.2014.199

D Knowland, 2014, Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke., Neuron., 82, 603-617, 10.1016/j.neuron.2014.03.003

S Prasad, 2014, Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview., J Pharmacovigil., 2, 125, 10.4172/2329-6887.1000125

A Willyerd FA , Empey PE , Philbrick, 2016, Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans., J Neurotrauma., 33, 226-231, 10.1089/neu.2015.3879

N Saunders, 2015, Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives?, Front Neurosci., 9, 385, 10.3389/fnins.2015.00385

J Iliff, 2015, Implications of the discovery of brain lymphatic pathways., Lancet Neurol., 14, 977-9, 10.1016/S1474-4422(15)00221-5

N Korogod, 2015, Ultrastructural analysis of adult mouse neocortex comparing aldehyde perfusion with cryo fixation., eLife., 4, e05793, 10.7554/eLife.05793

M Hammarlund-Udenaes, 2008, On the rate and extent of drug delivery to the brain., Pharm Res., 25, 1737-1750, 10.1007/s11095-007-9502-2

E de Lange, 2002, Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain., Clin Pharmacokinet., 41, 691-703, 10.2165/00003088-200241100-00001

A Louveau, 2015, Structural and functional features of central nervous system lymphatic vessels., Nature., 523, 337-341, 10.1038/nature14432

Thông tin
Thông tin xuất bản

F1000Research

Tập 5

313

Thông tin tác giả